background image

Paid Clinical Trials Lakeland

Discover 1,687 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting
Active & Responsive

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: 40 recruiting locations
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting
Active & Responsive

Fenofibrate for Prevention of DR Worsening

for
Diabetic Retinopathy
Location: 58 recruiting locations
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 18 - 70+

Code: NCT04661358

Phase3, Recruiting
Active & Responsive

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

for
AAA, AAA - Abdominal Aortic Aneurysm
Location: 24 recruiting locations
Sponsor: Endologix

Sex: All

Age: 21+

Code: NCT05064540

Recruiting
Active & Responsive

A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)

for
Lower Extremity Acute Limb Ischemia, LE ALI
Location: 9 recruiting locations
Sponsor: Penumbra Inc.

Sex: All

Age: 18+

Code: NCT06747117

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

for
Weight Loss
Location: 113 recruiting locations
Sponsor: Viking Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07104383

Phase3, Recruiting
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: 33 recruiting locations
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase2, Recruiting
Active & Responsive

Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

for
Advanced NSCLC, Metastatic Lung Cancer
Location: 19 recruiting locations
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05609578

Phase2, Recruiting
Active & Responsive

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

for
Breast Cancer
Location: 99 recruiting locations
Sponsor: Agendia

Sex: All

Age: 18+

Code: NCT03053193

Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

for
Moderately to Severely Active Ulcerative Colitis
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06589986

Phase3, Recruiting